All
SABCS 2008 Marks the First Year of Collaboration
December 11th 2008The American Association of Cancer Research has joined the Cancer Therapy Research Center at the University of Texas Health Science Center at San Antonio, and the Baylor College of Medicine in putting on this year's San Antonio Breast Cancer Symposium.
Lung Cancer Patients Living Longer With Targeted Drugs
October 24th 2008Avastin is one of a new class of drugs that works by targeting the newly formed blood vessels that develop around tumors, a process called antiangiogenesis—recent studies have seen positive survival results in colon cancer and now lung cancer.
The Pitfalls and Promises of Diagnosing Ovarian Cancer Early
October 24th 2008Ovarian cancer, also known as “the silent killer,” may soon be detected earlier, giving women improved survival rates, with the recognition of specific early warning signs which including abdominal pain, abdominal bloating, urinary urgency or frequency, pelvic and lower back pressure, loss of appetite or feeling full quickly and abnormal vaginal bleeding.
CURExtra - Monitoring for Bladder Cancer Recurrence
October 23rd 2008Bladder cancer has one of the highest recurrence rates, but there are many tests and ways to monitor for early detection including, urine cytology, cystoscopy, BladderChek, UroVysion, FISH and ImmunoCyt Bladder Cancer Monitoring Test.
CURExtra - Evista Gives Women Another Choice for Preventing Breast Cancer
October 23rd 2008The STAR (Study of Tamoxifen and Raloxifene) trial, one of the largest breast cancer prevention trials ever conducted, showed that five years of Evista is as effective as tamoxifen in lowering risk of developing breast cancer, giving high-risk women a new option for prevention
CURExtra - Prostate Cancer Therapy: Men Guided by What They Fear, What They Hear
October 23rd 2008Choosing which cancer treatment is right for you is tough, but it is important to weigh the risks and benefits of each option and consider getting a second opinion, and studies show that most men diagnosed with prostate cancer base treatment decisions on preconceived ideas and fears or stories heard from other patients rather than logical evaluation of each treatment option—chemotherapy, radiation, surgery—and information from doctors.